
Christopher W. Fulton
Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856 |
| Total Applications | 3373 |
| Issued Applications | 2875 |
| Pending Applications | 85 |
| Abandoned Applications | 419 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6408135
[patent_doc_number] => 20020037860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Method for reducing or preventing the establishment, growth or metastasis of cancer by administering indazole peptidomimetics PAR-1 antagonist and optionally PAR-2 antagonists'
[patent_app_type] => new
[patent_app_number] => 09/865511
[patent_app_country] => US
[patent_app_date] => 2001-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 20027
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037860.pdf
[firstpage_image] =>[orig_patent_app_number] => 09865511
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/865511 | Method for reducing or preventing the establishment, growth or metastasis of cancer by administering indazole peptidomimetics PAR-1 antagonist and optionally PAR-2 antagonists | May 24, 2001 | Abandoned |
| 09/720481 | Novel peptide y-2 | May 22, 2001 | Abandoned |
Array
(
[id] => 5889066
[patent_doc_number] => 20020013278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'Prodrug of an ice inhibitor'
[patent_app_type] => new
[patent_app_number] => 09/860750
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8065
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20020013278.pdf
[firstpage_image] =>[orig_patent_app_number] => 09860750
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/860750 | Prodrug of an ice inhibitor | May 17, 2001 | Issued |
Array
(
[id] => 6472882
[patent_doc_number] => 20020151473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Constrained helical peptides and methods of making same'
[patent_app_type] => new
[patent_app_number] => 09/854816
[patent_app_country] => US
[patent_app_date] => 2001-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 59206
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151473.pdf
[firstpage_image] =>[orig_patent_app_number] => 09854816
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/854816 | Constrained helical peptides and methods of making same | May 14, 2001 | Abandoned |
Array
(
[id] => 1148179
[patent_doc_number] => 06774221
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-10
[patent_title] => 'Process for eliminating N-terminal methionine'
[patent_app_type] => B1
[patent_app_number] => 09/806871
[patent_app_country] => US
[patent_app_date] => 2001-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17225
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/774/06774221.pdf
[firstpage_image] =>[orig_patent_app_number] => 09806871
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/806871 | Process for eliminating N-terminal methionine | May 6, 2001 | Issued |
Array
(
[id] => 6870573
[patent_doc_number] => 20030083263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Pentapeptide compounds and uses related thereto'
[patent_app_type] => new
[patent_app_number] => 09/845786
[patent_app_country] => US
[patent_app_date] => 2001-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 18351
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083263.pdf
[firstpage_image] =>[orig_patent_app_number] => 09845786
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/845786 | Pentapeptide compounds and uses related thereto | Apr 29, 2001 | Abandoned |
Array
(
[id] => 6243022
[patent_doc_number] => 20020045574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Glycopeptide antibacterial compounds and methods of using same'
[patent_app_type] => new
[patent_app_number] => 09/840927
[patent_app_country] => US
[patent_app_date] => 2001-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11452
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045574.pdf
[firstpage_image] =>[orig_patent_app_number] => 09840927
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/840927 | Glycopeptide antibacterial compounds and methods of using same | Apr 24, 2001 | Abandoned |
Array
(
[id] => 993747
[patent_doc_number] => 06916846
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-12
[patent_title] => 'Coumermycin analogs as chemical dimerizers of chimeric proteins'
[patent_app_type] => utility
[patent_app_number] => 09/840260
[patent_app_country] => US
[patent_app_date] => 2001-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6824
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/916/06916846.pdf
[firstpage_image] =>[orig_patent_app_number] => 09840260
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/840260 | Coumermycin analogs as chemical dimerizers of chimeric proteins | Apr 22, 2001 | Issued |
Array
(
[id] => 1413937
[patent_doc_number] => 06525024
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-25
[patent_title] => 'Inhibitors of the ICE/ced-3 family of cysteine proteases'
[patent_app_type] => B1
[patent_app_number] => 09/837614
[patent_app_country] => US
[patent_app_date] => 2001-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15112
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1021
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/525/06525024.pdf
[firstpage_image] =>[orig_patent_app_number] => 09837614
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/837614 | Inhibitors of the ICE/ced-3 family of cysteine proteases | Apr 16, 2001 | Issued |
Array
(
[id] => 6623558
[patent_doc_number] => 20020016294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties'
[patent_app_type] => new
[patent_app_number] => 09/836636
[patent_app_country] => US
[patent_app_date] => 2001-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31947
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20020016294.pdf
[firstpage_image] =>[orig_patent_app_number] => 09836636
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/836636 | Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties | Apr 16, 2001 | Issued |
Array
(
[id] => 5969023
[patent_doc_number] => 20020091089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => '(Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases'
[patent_app_type] => new
[patent_app_number] => 09/836442
[patent_app_country] => US
[patent_app_date] => 2001-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34712
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20020091089.pdf
[firstpage_image] =>[orig_patent_app_number] => 09836442
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/836442 | (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases | Apr 15, 2001 | Abandoned |
Array
(
[id] => 7078997
[patent_doc_number] => 20010041673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-15
[patent_title] => 'Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues'
[patent_app_type] => new
[patent_app_number] => 09/834477
[patent_app_country] => US
[patent_app_date] => 2001-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29803
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20010041673.pdf
[firstpage_image] =>[orig_patent_app_number] => 09834477
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/834477 | Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues | Apr 12, 2001 | Abandoned |
Array
(
[id] => 1148075
[patent_doc_number] => 06774211
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-10
[patent_title] => 'Peptide antiangiogenic drugs'
[patent_app_type] => B1
[patent_app_number] => 09/833196
[patent_app_country] => US
[patent_app_date] => 2001-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75685
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/774/06774211.pdf
[firstpage_image] =>[orig_patent_app_number] => 09833196
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/833196 | Peptide antiangiogenic drugs | Apr 10, 2001 | Issued |
Array
(
[id] => 1131553
[patent_doc_number] => 06787635
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-09-07
[patent_title] => 'Solid phase synthesis supports and methods'
[patent_app_type] => B2
[patent_app_number] => 09/827107
[patent_app_country] => US
[patent_app_date] => 2001-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8807
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/787/06787635.pdf
[firstpage_image] =>[orig_patent_app_number] => 09827107
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/827107 | Solid phase synthesis supports and methods | Apr 4, 2001 | Issued |
Array
(
[id] => 1180620
[patent_doc_number] => 06740678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-25
[patent_title] => 'Method of treatment of cardiovascular injuries'
[patent_app_type] => B2
[patent_app_number] => 09/822765
[patent_app_country] => US
[patent_app_date] => 2001-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 13
[patent_no_of_words] => 11441
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/740/06740678.pdf
[firstpage_image] =>[orig_patent_app_number] => 09822765
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/822765 | Method of treatment of cardiovascular injuries | Mar 29, 2001 | Issued |
Array
(
[id] => 6225767
[patent_doc_number] => 20020004594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-10
[patent_title] => 'Phosphoramidates and methods therefor'
[patent_app_type] => new
[patent_app_number] => 09/822376
[patent_app_country] => US
[patent_app_date] => 2001-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15245
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20020004594.pdf
[firstpage_image] =>[orig_patent_app_number] => 09822376
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/822376 | Phosphoramidates and methods therefor | Mar 29, 2001 | Issued |
| 09/806121 | Caspases and apoptosis | Mar 28, 2001 | Abandoned |
Array
(
[id] => 6898795
[patent_doc_number] => 20010046960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-29
[patent_title] => 'Novel perfluoroalkyl compounds and their methods of use and manufacture'
[patent_app_type] => new
[patent_app_number] => 09/817507
[patent_app_country] => US
[patent_app_date] => 2001-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 4982
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20010046960.pdf
[firstpage_image] =>[orig_patent_app_number] => 09817507
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/817507 | Perfluoroalkyl compounds and their methods of use and manufacture | Mar 25, 2001 | Issued |
Array
(
[id] => 6242293
[patent_doc_number] => 20020045231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies'
[patent_app_type] => new
[patent_app_number] => 09/817502
[patent_app_country] => US
[patent_app_date] => 2001-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15378
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045231.pdf
[firstpage_image] =>[orig_patent_app_number] => 09817502
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/817502 | Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies | Mar 25, 2001 | Abandoned |
Array
(
[id] => 1169654
[patent_doc_number] => 06753317
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-22
[patent_title] => 'Dmt-Tic di- and tri-peptide derivatives and related compositions and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/814558
[patent_app_country] => US
[patent_app_date] => 2001-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14907
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/753/06753317.pdf
[firstpage_image] =>[orig_patent_app_number] => 09814558
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/814558 | Dmt-Tic di- and tri-peptide derivatives and related compositions and methods of use | Mar 21, 2001 | Issued |